Daniel Hal Solomon

Massachusetts General Hospital

NIH Rank #2665
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$3M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#2,665
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3M across 3 grants · National rank #2665.

Top grants by award amount

Daniel Hal Solomon's NIH grant portfolio, ranked by award amount.

  • 5U01AR080985-02U01
    Treat-to-Target Serum Urate versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial (TRUST)
    $1.9M
    award amount
  • 5R01HL163580-03R01
    Rheumatoid Arthritis and the Risk of Cardiovascular Disease: Biomarkers Risk Prediction and Underlying Mechanisms
    $774.8K
    award amount
  • 5P30AR072577-08P30
    VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
    $255.8K
    award amount

Affiliations

Institutions that have administered grants for Daniel Hal Solomon.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Massachusetts General Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2665
  6. 2024
    Entered Top 25% Nationally
    Ranked #2665
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions